|
|
|
|
|
|
| Global CRO reinforces commitment to key stakeholder group with sponsorship and extensive presence at industry site event |
Raleigh, N.C., Oct 3, 2014 - (ACN Newswire) - INC Research, a leading, global Phase I to IV clinical research organization (CRO), today announced plans for an extensive presence at the 2014 Society for Clinical Research Sites' (SCRS) Site Solutions Summit taking place Oct. 10-12, 2014, on Amelia Island, Fla. Recognizing the critical role clinical research sites play in bringing new medicines to market for patients, the Company will be maximizing the opportunities available at the SCRS Summit to deepen its connections with this important stakeholder group and contribute to the ongoing dialogue on how CROs and sites can work more effectively together for the benefit of sponsors and patients.
"INC Research is proud to be contributing to the SCRS Site Solutions Summit because we recognize the impact clinical research sites have on the overall success of clinical trials," said CEO Jamie Macdonald. "Through new technologies, insights from our thought leaders and a reception recognizing the tremendous contribution sites make across the clinical research enterprise, we are demonstrating our efforts to really listen to what sites need so we can make these essential relationships more effective and efficient."
Connect with us
Located at Booth # 34, INC Research will unveil a new mobile application designed to connect with sites and solicit their feedback on key elements in an investigator portal. Sites also will be asked to participate in an interactive poll that will enable INC Research to better understand their perspective on key topics and what is important to them in a CRO relationship.
Hear from INC Research thought leaders on sites
The SCRS Site Solutions Summit provides a unique platform for dialogue, development and efficiency improvement across all organizations in the clinical research enterprise. More than 600 attendees representing nearly 100 sponsor/CRO organizations and sites will participate. INC Research thought leaders will contribute to discussions on the following topics:
-- Carol Aliyar, Senior Vice President, Study Start-Up - "Site Business Development: Optimizing Site Selection" (Friday, Oct. 10 from 9 a.m. - 12 p.m.) and "Metrics, Metrics, Metrics" (Saturday, Oct. 11 from 1:45 - 2:45 p.m.)
-- Tammy Ice, Senior Director, Global Patient Recruitment - "The New World of On-Line Patient Recruitment" (Saturday, Oct. 11 from 1:45 p.m. - 2:45 p.m.)
-- Travis Caudill, Director, Feasibility & Site Identification, Regulatory & Site Start-Up - "The Big Bang- Leveraging Technology Like a Genius" (Saturday, Oct. 11 from 1:45 - 2:45 p.m.)
-- Todd Esporas, Vice President, Site Start-Up & Regulatory - "Fair Market Value" (Saturday, Oct. 11 from 3:15 - 4:15 p.m.)
-- Clare Grace, Vice President, Site and Patient Access - "New Technologies: How Will They Affect My Site?" (Saturday, Oct. 11 from 4:45 - 5:45 p.m.)
-- Jill Collins, Senior Director, Integrated Clinical Processes and Clinical Innovation - "Risk-based Monitoring: The site effect after year one" (Saturday, Oct. 11 from 4:45 - 5:45 p.m.)
Investigative Site Reception and Eagle Award Finalist
As part of its ongoing commitment to strengthen site relationships globally, INC Research is hosting a Site Appreciation Reception for clinical research sites on Saturday, Oct. 11 following the Eagle Award Ceremony. As a Global Impact Partner to SCRS and a finalist for the CRO recipient of SCRS' 2014 Eagle Award, INC Research is broadening its relationships with sites even further through this event in an effort to gain insights into how the industry can improve the quality and depth of support that sites receive. INC Research CEO Jamie Macdonald and Vice President, Site and Patient Access, Clare Grace will be available at the site reception to meet with clinical research investigators and site personnel to discuss ways to work better together.
INC Research is focused on connecting customers, sites and patients to improve world health. Ranked the "Top CRO to Work with" in the 2013 CenterWatch Global Investigative Site Relationship Survey of more than 2,000 sites globally, the Company is committed to developing and nurturing deep site relationships that ensure rapid study start-up, smooth study conduct and consistently excellent results. For more information, messages to investigative sites from INC Research CEO Jamie Macdonald and INC Research Project Leaders can be viewed at http://youtu.be/jYz-akCNgwM and http://youtu.be/xn23jhcTxjc. Or, for more information on the Site Solutions Summit, please visit www.SiteSolutionsSummit.com or www.MySCRS.org.
About INC Research
INC Research is a leading global contract research organization (CRO) providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industry. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market. We were ranked "Top CRO to Work With" by sites worldwide in the 2013 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, NC, with operations across six continents and experience spanning more than 100 countries.
Contact:
Lori Dorer, Media +1-513-345-1685
###
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: INC RESEARCH, LLC via Globenewswire
Topic: Press release summary
Source: INC Research, LLC
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
|
